caffeine has been researched along with Anochlesia in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "HP produced a full blown catalepsy, akinesia and a significant impairment in locomotion and antioxidant status." | 1.48 | Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice. ( Anoopkumar-Dukie, S; Arora, D; Grant, GD; Hall, S; Kinra, M; Mallik, SB; Mudgal, J; Nampoothiri, M; Rao, CM, 2018) |
| "Epigallocatechin gallate (EGCG) is a major component of tea and its known interactions with caffeine make it worthwhile to further study them by investigating the influence of EGCG on the anticataleptic and locomotor-sensitizing effects of caffeine." | 1.42 | Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice. ( Acquas, E; Arote, S; Cotti, E; Gaikar, M; Kasture, SB; Kasture, V; Rosas, M; Salve, B, 2015) |
| "In order to assess whether caffeine and theophylline have the same potency and efficacy to reverse the impairment of motor function caused by acute or chronic interruption of striatal dopamine transmission, a comparison of their dose-response relationship was made in the acute model of haloperidol-induced catalepsy, and the chronic model of unilateral lesion of the dopamine nigrostriatal pathway with 6-hydroxydopamine." | 1.39 | Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats. ( Acuña-Lizama, MM; Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL, 2013) |
| "Haloperidol is a classical antipsychotic drug, which produces extra-pyrimidal Parkinson's symptoms (EPS)." | 1.35 | Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease. ( Barodia, SK; Luthra, PM; Raghubir, R, 2009) |
| "Treatment with caffeine significantly increased locomotion reduced by haloperidol, but not at all doses tested." | 1.35 | Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease. ( Goode, T; Harris, A; Trevitt, J; Vallance, C, 2009) |
| "Caffeine-treated rats also had higher catalepsy latency scores compared with control rats (P<0." | 1.35 | Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine. ( Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL; Heredia-López, FJ; Moo-Puc, RE; Pineda, JC; Villanueva-Toledo, JR, 2009) |
| "THP inhibited catalepsy intensity with an ED(50) of 0." | 1.32 | Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy. ( Alvarez-Cervera, FJ; Arankowsky-Sandoval, G; Góngora-Alfaro, JL; Heredia-López, F; Moo-Puc, RE; Pineda, JC, 2003) |
| "Pretreatment with caffeine (25 mg/kg, IP, -10 min) blocked the inhibition of CAR produced by the adenosine agonists, suggesting the event is mediated via purinergic receptors." | 1.29 | Adenosine agonists reduce conditioned avoidance responding in the rat. ( Jarvis, MF; Martin, GE; Rossi, DJ, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, D | 1 |
| Mudgal, J | 1 |
| Nampoothiri, M | 1 |
| Mallik, SB | 1 |
| Kinra, M | 1 |
| Hall, S | 1 |
| Anoopkumar-Dukie, S | 1 |
| Grant, GD | 1 |
| Rao, CM | 1 |
| Kasture, SB | 1 |
| Gaikar, M | 1 |
| Kasture, V | 1 |
| Arote, S | 1 |
| Salve, B | 1 |
| Rosas, M | 1 |
| Cotti, E | 1 |
| Acquas, E | 1 |
| Varty, GB | 1 |
| Hodgson, RA | 1 |
| Pond, AJ | 1 |
| Grzelak, ME | 1 |
| Parker, EM | 1 |
| Hunter, JC | 1 |
| Luthra, PM | 1 |
| Barodia, SK | 1 |
| Raghubir, R | 1 |
| Kasture, S | 1 |
| Barhate, S | 1 |
| Mohan, M | 1 |
| Ballero, M | 1 |
| Sanna, C | 1 |
| Maxia, A | 1 |
| Trevitt, J | 1 |
| Vallance, C | 1 |
| Harris, A | 1 |
| Goode, T | 1 |
| Góngora-Alfaro, JL | 3 |
| Moo-Puc, RE | 2 |
| Villanueva-Toledo, JR | 1 |
| Alvarez-Cervera, FJ | 3 |
| Bata-García, JL | 2 |
| Heredia-López, FJ | 1 |
| Pineda, JC | 2 |
| Acuña-Lizama, MM | 1 |
| Arankowsky-Sandoval, G | 1 |
| Heredia-López, F | 1 |
| Martin, GE | 1 |
| Rossi, DJ | 1 |
| Jarvis, MF | 1 |
| Ward, RP | 1 |
| Dorsa, DM | 1 |
| Shiozaki, S | 1 |
| Ichikawa, S | 1 |
| Nakamura, J | 1 |
| Kitamura, S | 1 |
| Yamada, K | 1 |
| Kuwana, Y | 1 |
| Chen, JF | 1 |
| Moratalla, R | 1 |
| Impagnatiello, F | 1 |
| Grandy, DK | 1 |
| Cuellar, B | 1 |
| Rubinstein, M | 1 |
| Beilstein, MA | 1 |
| Hackett, E | 1 |
| Fink, JS | 1 |
| Low, MJ | 1 |
| Ongini, E | 1 |
| Schwarzschild, MA | 1 |
| Zetler, G | 1 |
| Boissier, JR | 1 |
| Simon, P | 1 |
| Villeneuve, A | 1 |
| Larousse, C | 1 |
| Fog, R | 1 |
| Marcus, RJ | 1 |
| Winters, WD | 1 |
| Roberts, E | 1 |
| Simonsen, DG | 1 |
1 review available for caffeine and Anochlesia
| Article | Year |
|---|---|
On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
Topics: Amphetamine; Animals; Basal Ganglia; Caffeine; Catalepsy; Cocaine; Compulsive Behavior; Corpus Stria | 1972 |
16 other studies available for caffeine and Anochlesia
| Article | Year |
|---|---|
Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catalepsy; Cyclooxygenase Inhibitor | 2018 |
Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.
Topics: Animals; Antipsychotic Agents; Caffeine; Catalepsy; Catechin; Disease Models, Animal; Dose-Response | 2015 |
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antipsychotic Agents; Caffeine; Catalepsy; Cebus; Corpus | 2008 |
Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Caffeine; Catalepsy; Corpus Striatum; Disease M | 2009 |
Caffeine withdrawal retains anticataleptic activity but Withania somnifera withdrawal potentiates haloperidol-induced catalepsy in mice.
Topics: Analysis of Variance; Animals; Caffeine; Catalepsy; Haloperidol; Mice; Nervous System; Plant Extract | 2009 |
Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease.
Topics: Animals; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Male; Parkinson Disease | 2009 |
Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
Topics: Animals; Caffeine; Catalepsy; Central Nervous System Stimulants; Disease Susceptibility; Dopamine D2 | 2009 |
Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats.
Topics: Animals; Caffeine; Catalepsy; Corpus Striatum; Dopaminergic Neurons; Dose-Response Relationship, Dru | 2013 |
Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.
Topics: Animals; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Male; M | 2003 |
Adenosine agonists reduce conditioned avoidance responding in the rat.
Topics: Adenosine; Animals; Antipsychotic Agents; Avoidance Learning; Binding, Competitive; Caffeine; Catale | 1993 |
Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Topics: Adenosine; Animals; Antipsychotic Agents; Behavior, Animal; Caffeine; Catalepsy; Clozapine; Corpus S | 1999 |
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Antiparkinson Agents; Antipsychoti | 1999 |
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.
Topics: Adenosine; Amphetamines; Animals; Caffeine; Catalepsy; Corpus Striatum; Dopamine Antagonists; Enkeph | 2001 |
Drug-induced catalepsy as influenced by convulsant and anticonvulsant drugs.
Topics: Animals; Anticonvulsants; Arecoline; Bemegride; Caffeine; Catalepsy; Central Nervous System Stimulan | 1973 |
Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Biperiden; Caffeine; Catalepsy; Central Nervous Sy | 1968 |
Neuropharmacological studies of imidazole-4-acetic acid actions in the mouse and rat.
Topics: Acetates; Animals; Ataxia; Behavior; Caffeine; Catalepsy; Central Nervous System; Drug Interactions; | 1971 |